AristaMD Raises $18M to Expand eConsults Platform to Improve Patient Outcomes

Highlights on this story:

AristaMD has raised $18 million in Series B led by Cigna Ventures and MemorialCare Innovation Fund (MCIF), with participation from Avalon Ventures, CU Healthcare Innovation Fund and Stanford Health Care.
Now more than ever, eConsults are a crucial resource in providing fast, efficient, HIPAA-compliant, and fully scalable access to specialists.

Annually there are around 20 million routine clinical referrals to specialists that could be addressed by eConsults and AristaMD is focused on providing more timely access to specialty care through its innovative eConsult platform.
The telehealth company empowers primary care providers to expand their scope and collaborate on patient care with a panel of on-call, board-certified specialists.

AristaMD, a San Diego, CA-based digital health company that provides a proprietary eConsult solution to connect primary care providers (PCPs) with timely, documented specialist insights, has raised $18 million in Series B funding. The round was led by Cigna Ventures and MemorialCare Innovation Fund (MCIF), with participation from Avalon Ventures, CU Healthcare Innovation Fund and Stanford Health Care. The company will use the funding to accelerate expansion of its proprietary eConsult platform across the country.

Founded in 2014, AristaMD is focused on accelerating access to specialty care and reducing unnecessary healthcare expense. Designed by practicing physicians, its eConsult solution empowers primary care providers (PCPs) to expand their scope of practice and collaborate on patient care with a highly respected panel of on-demand, board-certified specialists. AristaMD has over five years of data demonstrating that its eConsult solution reduces the need for routine clinical specialist referrals by over 70% and has a significant positive impact on patient care.

By utilizing eConsults, primary care providers retain more low-acuity common condition cases that are frequently referred to specialists, clogging waitlists and limiting specialists’ ability to address higher acuity cases in a timely fashion. Empowering PCPs to operate at the top of their license allows patients to have their needs addressed faster, reducing avoidable ED visits and hospitalizations that can occur when patients have to wait too long to be seen by a specialist. This ultimately improves outcomes and overall patient satisfaction.

“Every year there are approximately 20 million routine specialist referrals that could be addressed by eConsults–those unnecessary referrals have significant consequences including billions of wasted dollars,” said Brooke LeVasseur, CEO of AristaMD. “We are honored to receive such strong validation from major health plans and payors and are eager to leverage the capital and deep market experience of our new investors to springboard into a new growth phase for the company. We are committed to continue working toward our goal of transforming primary care to improve population health outcomes by improving and better allocating healthcare resources.”